Performance and Reproducibility of Large Language Models in Named Entity Recognition: Considerations for the Use in

Jürgen Dietrich1, André Hollstein2

  • 1Pharmaceuticals, Medical Affairs and Pharmacovigilance, Data Science and Insights, Bayer AG, Müllerstr. 178, 13353, Berlin, Germany. juergen.dietrich@bayer.com.

Drug Safety
|December 11, 2024
PubMed
Abstract

Related Concept Videos